Sanofi to continue opportunistic share buybacks
PARIS Feb 7 (Reuters) - French drugmaker Sanofi plans to continue buying back shares on an opportunistic basis this year, according to slides published on its website ahead of a presentation to analysts on Thursday.
The company repurchased a total of 822 million euros ($1.11 billion) worth of shares last year, according to the slides. ($1 = 0.7387 euros) (Reporting by Elena Berton; Editing by James Regan)
- Atheists face death in 13 countries, global discrimination: study
- Signer says suffered schizophrenic episode at Mandela memorial |
- Missouri executes man for killing good Samaritan motorist in 1994
- Thai military chief rebuffs meeting request in blow to protesters |
- Apple scores legal victory over Samsung in South Korea